鼻窦炎随机临床试验的注册实践:一项横断面综述
该横断面综述检索PubMed和ClinicalTrials.gov,评估鼻窦炎随机临床试验(RCT)的注册报告情况。179项RCT中94项(52.5%)报告注册号;70项前瞻注册RCT中22项(31%)存在至少1处注册与发表重大不一致;52项注册试验中21项(40%)在注册平台列出发表。作者建议严格遵循RCT注册政策并加强准确报告的执行。
要点
- 179项鼻窦炎RCT中94项(52.5%)在发表中报告了注册号。
- 70项前瞻注册RCT中22项(31%)存在至少1处注册与发表的重大不一致。
- ClinicalTrials.gov上52项完成的试验中21项(40%)在注册平台列出了发表。
核心结论
- 已发表的鼻窦炎RCT常不包含试验注册号,且注册的RCT常未发表。
- 注册的RCT常显示选择性结局报告并倾向于阳性结果。
- 作者建议严格遵循RCT注册政策并加强准确报告的执行,以帮助强化临床决策背后的证据。
研究设计与样本
- 横断面综述,样本来自2017年10月31日PubMed(MEDLINE)检索,关键词为「sinusitis OR rhinosinusitis OR rhinitis」,限定日期2015年1月1日至2017年10月31日及研究类型RCT。
- 主要结局分析纳入179项RCT;次要结局分析纳入70项在患者入组前或入组期间注册的RCT。
- 第三结局于2018年9月4日在ClinicalTrials.gov检索,关键词为「sinusitis OR rhinosinusitis」,限定日期2013年1月1日至2015年10月31日,识别52项完成的临床试验。
- 全部分析于2018年10月29日至2018年10月31日进行。
主要发现
- 179项RCT中94项(52.5%)在发表中报告了注册号。
- 70项前瞻注册RCT中22项(31%)存在至少1处注册与发表之间的重大不一致。
- ClinicalTrials.gov上52项完成的临床试验中21项(40%)在注册平台列出了发表。
临床怎么用
- 作者建议严格遵循RCT注册政策并加强准确报告的执行,以帮助强化临床决策背后的证据。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Randomized clinical trials (RCTs) play an important role in the development of clinical practice guidelines and in clinical decision making. Little is known about the registration practices of RCTs in the diagnosis and treatment of rhinosinusitis. OBJECTIVES: The primary outcome was the frequency of reported RCT registry numbers by authors of rhinosinusitis RCTs. A secondary outcome was the rates of selective reporting bias in RCTs that were prospectively registered. A tertiary outcome end point was the frequency of publication of RCTs registered on ClinicalTrials.gov. EVIDENCE REVIEW: Our sample was derived from a PubMed (MEDLINE) search performed on October 31, 2017, using the keywords "sinusitis OR rhinosinusitis OR rhinitis," and filtering by date (January 1, 2015, through October 31, 2017) and study type (RCT). Studies that were considered an RCT were included for the primary outcome analysis. All RCTs that were registered prior to or during patient enrollment were included for secondary outcome analysis. For the tertiary outcome, a search was performed on ClinicalTrials.gov on September 4, 2018, using the keywords "sinusitis OR rhinosinusitis," and filtering by date (January 1, 2013, through October 31, 2015). All analysis took place between October 29, 2018, and October 31, 2018. FINDINGS: A total of 179 RCTs were analyzed for our primary outcome: 94 (52.5%) included a registration number in their publication, and 70 (39.1%) were included for secondary outcome analysis of rates of selective reporting bias. Of these 70 RCTs, 22 (31%) were found to have at least 1 major discrepancy between trial registration and publication. For the tertiary outcome, 52 completed clinical trials were identified on ClinicalTrials.gov, of which 21 (40%) had listed publication in the registry. CONCLUSIONS AND RELEVANCE: We found that published rhinosinusitis RCTs frequently do not include a trial registration number and that registered RCTs frequently are not published. Furthermore, RCTs that are registered often display selective reporting of their outcomes and frequently favor positive results. We recommend strict adherence to RCT registration policies and the enforcement of accurate reporting to help strengthen the evidence behind clinical decision making.
引用
- Ross A, George D, Wayant C, et al. Registration Practices of Randomized Clinical Trials in Rhinosinusitis: A Cross-sectional Review. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30920611. doi:10.1001/jamaoto.2019.0145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。